mnov  stock quote for medicinova inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices medicinova inc nasdaq mnov us markets closed adchoices  ▲   after hours     july    pm edt delayed  minutes nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news company overview of medicinova inc bloomberg  el paso electric company ee reaches  after  up move medicinova mnov si increased by  the bibey post  days ago positive news coverage extremely likely to impact medicinova nasdaqmnov stock price breeze  medicinova nasdaqmnov receiving favorable media coverage study shows themarketsdailycom  positive media coverage very likely to impact medicinova mnov stock price themarketsdailycom  medicinova inc nasdaqmnov institutional investors sentiment index improved in  q presstelegraphcom  edgemoor investment advisors has boosted its capital one finl cof position medicinova mnov shorts increased by  the bibey post  medicinova mnov earning somewhat positive press coverage analysis finds bns  medicinova inc mnov moves lower on volume spike for june  equities  stock radar viewing levels for medicinova inc mnov trikklescom  medicinova inc mnov moves lower on volume spike for june  equities  medicinova mnov earning favorable news coverage report finds breeze  brief medicinova completes offfloor distribution reuters  brief medicinova to offer offfloor distribution of shares reuters  brief medicinova to offer offfloor distribution of shares mnov marketsinsidercom  brief medicinova to offer offfloor distribution of shares reuters  yutaka kobayashi buys  shares of medicinova inc mnov stock bns  medicinova announces positive results investorshangoutcom  adchoices adchoices adchoices markets dow dow ▼    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support company  medicinova inc japanese site 語 search the site home company company about the company medicinova inc is a publiclytraded biopharmaceutical company focused on acquiring and developing novel smallmolecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the us market through strategic alliances primarily with japanese pharmaceutical companies medicinova holds rights to a diversified portfolio of clinical and preclinical product candidates each of which medicinova believes has a wellcharacterized and differentiated therapeutic profile attractive commercial potential and patent assets having claims of commercially adequate scope medicinova’s pipeline includes clinicalstage compounds for the treatment of acute exacerbations of asthma and copd progressive multiple sclerosis methamphetamine addiction neuropathic pain asthma interstitial cystitis and solid tumor cancers medicinova’s current strategy is to focus on mn ibudilast for neurological disorders mn for the treatment of acute exacerbations of asthma and mn for nash medicinova may pursue development independently or establish a strategic collaboration to support further development of its programs medicinova will seek to monetize its other product candidates at key value inflection points medicinova’s executive management team has extensive global development regulatory commercial and financial experience and manages its international clinical and manufacturing operations through efficient and costeffective utilization of contract research organizations headquartered in la jolla california medicinova has approximately  employees mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more current openings  medicinova inc japanese site 語 search the site home company careers current openings careers current openings current openings none at this time mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more management team  medicinova inc japanese site 語 search the site home company management team company management team management team yuichi iwaki md phd president and chief executive officer and founder dr iwaki holds three professorships at the university of southern california school of medicine in the departments of urology surgery and pathology and has been director of the transplantation immunology and immunogenetic laboratory since  he is also a visiting professor at the nihon university school of medicine kyushu university and toho university school of medicine in japan prior to joining the faculty at the university of southern california school of medicine dr iwaki held professorships at the university of pittsburgh school of medicine in the departments of surgery and pathology from  through  he received both his md and phd degrees from sapporo medical school in sapporo japan dr iwaki is the author of  peerreviewed publications and more than  books he has been advising pharmaceutical companies and venture capital funds regarding research and investment strategies for over  years and is a board member of several biotechnology companies masatsune okajima vice president and head of japanese office mr okajima joined medicinova in september  before joining medicinova mr okajima served as deputy general manager daiwa securities smbc co ltd from  through  mr okajima served as manager daiwa securities’ sb capital markets co ltd currently daiwa securities smbc co ltd as deputy general manager mr okajima was involved in pivotal phases of initial public offerings subsequent public offerings corporate bond issuances and mergers  acquisitions  in addition he handled investors relations and stock trading from  to  mr okajima served as manager sumitomo capital securities co ltd  mr okajima served in various positions at sumitomo bank ltd currently mitsui sumitomo bank between  and   mr okajima graduated with a bs degree from the department of science and technology tokyo science university kazuko matsuda md phd mph chief medical officer dr matsuda has served as vice president of clinical development for medicinova since  and is responsible for all clinical development  previously dr matsuda was a clinical advisor to medicinova for its mn and mn development programs  prior to joining medicinova dr matsuda was assistant professor university of southern california keck school of medicine after an appointment at the children’s hospital los angeles  dr matsuda commenced her residency in internal medicinepediatrics at michigan state university and completed a pediatric residency at loma linda university  she is a board certified pediatrician in both the united states and japan dr matsuda received her md and phd from sapporo medical school and mph from harvard university school of public health geoffrey o’brien jdmba vice president mr o’brien joined medicinova in june  prior to joining medicinova mr o’brien worked on wall street for  years as an equity research analyst and investment banker covering pharmaceutical and biotechnology companies at ubs dljcredit suisse first boston nomura and punk ziegel and was a vice president from  during his career as a senior equity research analyst on the sell side and buy side he focused on clinical scientific financial strategic and competitive analysis of development programs and marketed products he used this analysis to predict the future prospects of both developmentstage and established pharmaceutical and biotechnology companies at ubs mr o’brien worked on the specialty pharmaceuticals team which was ranked  in institutional investor magazine’s allamerica research team survey he executed acquisitions and equity offerings as a health care investment banker at dljcredit suisse first boston prior to graduate school mr o’brien worked on the successful development of a biotechnology product at the liposome company mr o’brien received a bs in chemistry cum laude from the university of delaware and completed his jd and mba simultaneously at vanderbilt law school and owen graduate school of management at vanderbilt university ryan selhorn cpa chief financial officer mr selhorn was appointed our chief financial officer effective march   mr selhorn joined the accounting services firm of signature analytics san diego llc as the vice president operations in july  after spending  years with grant thornton llp most recently as a senior manager in the audit practice and then in the national mergers and acquisitions group he has experience working with both public and private companies in many industries including life sciences biotech and medical devices mr selhorn is a licensed certified public accountant and received his bachelor’s degree in accounting and finance from georgetown university mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more home  medicinova inc japanese site 語 search the site medicinova is a biopharmaceutical company that is developingnovel therapeutics with a primary focus on neurology respiratoryand liver diseases with unmet medical needs mn for neurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn more mn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn more management team  medicinova inc japanese site 語 search the site home company management team company management team management team yuichi iwaki md phd president and chief executive officer and founder dr iwaki holds three professorships at the university of southern california school of medicine in the departments of urology surgery and pathology and has been director of the transplantation immunology and immunogenetic laboratory since  he is also a visiting professor at the nihon university school of medicine kyushu university and toho university school of medicine in japan prior to joining the faculty at the university of southern california school of medicine dr iwaki held professorships at the university of pittsburgh school of medicine in the departments of surgery and pathology from  through  he received both his md and phd degrees from sapporo medical school in sapporo japan dr iwaki is the author of  peerreviewed publications and more than  books he has been advising pharmaceutical companies and venture capital funds regarding research and investment strategies for over  years and is a board member of several biotechnology companies masatsune okajima vice president and head of japanese office mr okajima joined medicinova in september  before joining medicinova mr okajima served as deputy general manager daiwa securities smbc co ltd from  through  mr okajima served as manager daiwa securities’ sb capital markets co ltd currently daiwa securities smbc co ltd as deputy general manager mr okajima was involved in pivotal phases of initial public offerings subsequent public offerings corporate bond issuances and mergers  acquisitions  in addition he handled investors relations and stock trading from  to  mr okajima served as manager sumitomo capital securities co ltd  mr okajima served in various positions at sumitomo bank ltd currently mitsui sumitomo bank between  and   mr okajima graduated with a bs degree from the department of science and technology tokyo science university kazuko matsuda md phd mph chief medical officer dr matsuda has served as vice president of clinical development for medicinova since  and is responsible for all clinical development  previously dr matsuda was a clinical advisor to medicinova for its mn and mn development programs  prior to joining medicinova dr matsuda was assistant professor university of southern california keck school of medicine after an appointment at the children’s hospital los angeles  dr matsuda commenced her residency in internal medicinepediatrics at michigan state university and completed a pediatric residency at loma linda university  she is a board certified pediatrician in both the united states and japan dr matsuda received her md and phd from sapporo medical school and mph from harvard university school of public health geoffrey o’brien jdmba vice president mr o’brien joined medicinova in june  prior to joining medicinova mr o’brien worked on wall street for  years as an equity research analyst and investment banker covering pharmaceutical and biotechnology companies at ubs dljcredit suisse first boston nomura and punk ziegel and was a vice president from  during his career as a senior equity research analyst on the sell side and buy side he focused on clinical scientific financial strategic and competitive analysis of development programs and marketed products he used this analysis to predict the future prospects of both developmentstage and established pharmaceutical and biotechnology companies at ubs mr o’brien worked on the specialty pharmaceuticals team which was ranked  in institutional investor magazine’s allamerica research team survey he executed acquisitions and equity offerings as a health care investment banker at dljcredit suisse first boston prior to graduate school mr o’brien worked on the successful development of a biotechnology product at the liposome company mr o’brien received a bs in chemistry cum laude from the university of delaware and completed his jd and mba simultaneously at vanderbilt law school and owen graduate school of management at vanderbilt university ryan selhorn cpa chief financial officer mr selhorn was appointed our chief financial officer effective march   mr selhorn joined the accounting services firm of signature analytics san diego llc as the vice president operations in july  after spending  years with grant thornton llp most recently as a senior manager in the audit practice and then in the national mergers and acquisitions group he has experience working with both public and private companies in many industries including life sciences biotech and medical devices mr selhorn is a licensed certified public accountant and received his bachelor’s degree in accounting and finance from georgetown university mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more business development  medicinova inc japanese site 語 search the site home business development business development our strategy our goal is to build a sustainable biopharmaceutical business through the successful development and commercialization of differentiated products for the treatment of diseases with unmet medical needs in highvalue therapeutic areas key elements of our strategy are to concentrate on development of our prioritized product candidates mn mn ibudilast and mn we may either pursue the development and commercialization of these product candidates ourselves or enter into strategic alliances with larger pharmaceutical companies we intend to actively pursue strategic collaborations to draw on the development regulatory and commercialization expertise and financial resources of larger biotechnology and pharmaceutical partners maximize the value of the remainder of our diversified pipeline of existing product candidates we will strategically conduct development activities on the remainder of our existing product candidates to the extent that we deem any further activities necessary to maximize their value while pursuing a variety of initiatives to monetize these product candidates opportunistically inlicense additional product candidates through our global industry relationships over the long term we intend to expand our pipeline of inlicensed product candidates by continuing to cultivate and strengthen our business relationships with pharmaceutical companies in japan and other markets we believe that additional diversification and expansion of our pipeline of product candidates will help maximize our commercial opportunities and mitigate the risks inherent in drug development selectively add commercial capabilities as our product development programs mature to ensure our ability to build a sustainable business we plan to selectively add commercial capabilities to our management team to support our evolution into a commercial entity as our product development programs mature we may develop our own marketing and sales organization to promote or copromote certain of our product candidates mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more media archive  medicinova inc japanese site 語 search the site home investor relations media archive investor relations media archive medicinova in the news medicinova’s drug trial addresses methamphetamine dependency – san diego business journal – september    michael coffee chief business officer talks on ehealth radio network about a new asthma treatment to a new addiction treatment – september    dr yuichi iwaki selected as one of the  of the most inspiring people in pharmavoice julyaugust  – introduction – full article  interview with michael coffee chief business officer of medicinova on the international capitalist – june    medicinova asthma compound poised for latestage trials – san diego business journal – may   medicinova to move into phase  program – biotuesdays – may   national asthma awareness month what’s next in the treatment of acute asthma – newswise – may   san diego’s medicinova nears turning point with lead drug for asthma – xconomy – may   click to read about dr iwaki president  ceo of medicinova featured in pharmavoice – may   click to watch a segment featuring mn by nbc philadelphia  forwardlooking statements medicinova cautions you that statements included in the company’s conference calls press releases and other materials posted on or available through this website that are not a description of historical facts are forwardlooking statements the inclusion of forwardlooking statements should not be regarded as a representation by medicinova that any of its plans will be achieved actual results may differ materially from those discussed in the conference calls press releases and other materials posted on or available through this website due to the risks and uncertainties inherent in medicinova’s business including without limitation the progress and timing of its clinical trials difficulties or delays in developing testing obtaining regulatory approval manufacturing and commercializing its product candidates unexpected adverse side effects or inadequate therapeutic efficacy of its product candidates that could delay or prevent regulatory approval product development or commercialization or that could result in product liability claims maintenance and enforcement of medicinova’s licensing arrangements with its licensors the scope and validity of patent protection for its product candidates and other risks detailed in medicinova’s securities and exchange commission filings you are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date of such conference calls press releases and other materials all forwardlooking statements are qualified in their entirety by this cautionary statement and medicinova undertakes no obligation to revise or update such statements to reflect events or circumstances after the date made this caution is made under the safe harbor provisions of the private securities litigation reform act of  mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn moremn forneurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn moremn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more investor home  medicinova japanese site 語search the sitehomeinvestor relationsinvestor relationsinvestor homecorporate profilemedicinova inc is a publiclytraded biopharmaceutical company focused on acquiring and developing novel smallmolecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the us market through strategic alliances primarily with japanese pharmaceutical companies medicinova holds rights to a diversified portfolio of clinical and preclinical product candidates each of which medicinova believes has a wellcharacterized and differentiated therapeutic profile attractive commercial potential and patent assets having claims of commercially adequate more stock quote mnov common exchangenasdaq us dollarpricechange    volumedata as of   pm etminimum  minute delayrefresh quoteupcoming eventsmore there are currently no events scheduledwhats newthere are currently no items available receive email alertssign up to receive email alerts whenever medicinova inc posts new information to the site just enter your email address and click submit  replication or redistribution of edgar online inc content is expressly prohibited without the prior written consent of edgar online inc edgar online inc shall not be liable for any errors or delays in the content or for any actions taken in reliance thereoninvestor toolkitprint pageemail pagerss feedsemail alertsir contactsfinancial tear sheet mnov stock price  medicinova inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern p updated you can date someone who looks just like donald trump with this new online service p updated want to buy happiness splurge on these  things p this is what people really buy when they emotionally overspend hint it’s not designer clothes p updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer p updated the dark side of cruises p updated i want to buy my brothers out of our family home — but they want me to pay future sales fees p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated not even free money can make some people go to the gym p updated how realestate tv shows determine what buyers look for in a house p updated what eleanor roosevelt and helen gurley brown ate — and what we can learn from it to be replaced home investing quotes stocks united states mnov overview compare quotes stock screener earnings calendar sectors nasdaq mnov us nasdaq join td ameritrade find a broker medicinova inc watchlist createmnovalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones thursday’s top gaining and declining stocks may   at  pm et by marketwatch medicinova dives on asthma study results may   at  pm et by val brickates kennedy hp climbs netapp tumbles in afterhours trade may   at  pm et by carla mozee medicinova study doesnt yield significant results may   at  pm et drug stocks move higher in late trading mar   at  pm et by val brickates kennedy fridays biggest gaining and declining stocks aug   at  pm et by marketwatch the gap jm smucker ann taylor in view aug   at  am et by marketwatch medicinova to acquire avigen for  a share aug   at  am et by william l watts medicinova to buy avigen for share aug   at  am et by steve goldstein avigen holders would get net cash value plus m jun   at  am et by simon kennedy medicinova avigen agree terms of proposed deal jun   at  am et by simon kennedy medicinova reaches tentative deal to buy avigen jun   at  am et by steve goldstein medicinova proposes to acquire avigen dec   at  am et by aude lagorce medicinova makes offer for avigen dec   at  am et by aude lagorce medicinova reports progress in asthmadrug phase ii trial sep   at  am et by robert daniel nedicinova reports positive preliminary phase ii results sep   at  am et by simon kennedy medicinova withdraws plan for secondary stock offering nov   at  am et by mike maynard medicinova pulls public offering of m shares nov   at  am et by aude lagorce medicinova to focus on  drugs to stop asthma drug trial jun   at  am et by sarah turner medicinova to focus on mn mn jun   at  am et by steve goldstein stocks to watch radioshack assisted living concepts caesars entertainment feb   at  am et on the wall street journal signet jewelers medicinova biggest price decliners sig mnov may   at  pm et on the wall street journal stocks to watch hewlettpackard pandora tiffany may   at  am et on the wall street journal bitauto holdings medicinova biggest price gainers bita mnov jun   at  pm et on the wall street journal usana health sciences medicinova biggest price gainers usna mnov jun   at  pm et on the wall street journal railamerica medicinova biggest price decliners ra mnov mar   at  pm et on the wall street journal pzena investment management medicinova biggest price gainers pzn mnov apr   at  pm et on the wall street journal recent news other news press releases blankinship  foster llc buys ishares russell  wisdomtree dividend exfinancials  blankinship  foster llc buys ishares russell  wisdomtree dividend exfinancials fund spdr dow jones industrial average sells ishares msci all country asia ex japan index fund ishares russell  value ishares msci eafe jun   at  pm et on gurufocuscom q medicinova inc q medicinova inc apr   at  pm et on edgar online  edg  q k medicinovas ibudilast shows treatment effect in als patients shares ahead  premarket medicinovas ibudilast shows treatment effect in als patients shares ahead  premarket apr   at  am et on seeking alpha medicinovas mn good trial but what about generic riluzole mar   at  am et on seeking alpha change in leadership for nash coming mar   at  pm et on seeking alpha address to congress quick picks mar   at  am et on seeking alpha k medicinova inc feb   at  pm et on edgar online  edg  q k biggest movers in manufacturing stocks now – akba abio glmd kmph dec   at  am et on investorplacecom medicinovas midstage study of mn in progressive ms to continue as planned dec   at  am et on seeking alpha adds and drops from the nasdaq biotech index dec   at  pm et on seeking alpha outcomes data showed als patients who discontinued treatment with medicinovas ibudilast showed declines in muscle strength dec   at  am et on seeking alpha q medicinova inc oct   at  pm et on edgar online  edg  q k nash event today to inform investors oct   at  am et on seeking alpha  biotechnology stocks to buy now sep   at  am et on investorplacecom allergan examining the premiums paid sep   at  am et on seeking alpha allergans tobira takeover stokes nash stocks sep   at  am et on seeking alpha hottest manufacturing stocks now – tatt tnxp nk aldr aug   at  pm et on investorplacecom  biotechnology stocks to buy now aug   at  am et on investorplacecom  biotechnology stocks to buy now aug   at  am et on investorplacecom some potential nash plays jul   at  pm et on seeking alpha medicinova announces positive results from a glioblastoma animal model study presented at the  american society of clinical oncology annual meeting in chicago illinois medicinova announces positive results from a glioblastoma animal model study presented at the  american society of clinical oncology annual meeting in chicago illinois jun   at  pm et on globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the american academy of neurology aan th annual meeting in boston medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the american academy of neurology aan th annual meeting in boston apr   at  pm et on globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the  american society of clinical oncology annual meeting in chicago illinois apr   at  pm et on globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the th quadrennial meeting of the world federation of neurooncology societies in zurich switzerland feb   at  pm et on globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the american academy of neurology aan th annual meeting in boston feb   at  pm et on globenewswire medicinova announces positive findings from completed trial of mn ibudilast in methamphetamine dependence presented at the th winter conference on brain research feb   at  pm et on globenewswire medicinova to attend mizuho healthcare conference in new york feb   at  pm et on globenewswire medicinova announces publication of positive findings on mn ibudilast in alcohol dependence jan   at  pm et on globenewswire medicinova announces european commission grants orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis dec   at  pm et on globenewswire medicinova announces phase b trial of mn ibudilast in progressive ms will continue as planned following dsmb review of interim efficacy analysis dec   at  am et on globenewswire medicinova added to nasdaq biotechnology index dec   at  am et on globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the th international symposium on alsmnd in dublin ireland dec   at  am et on globenewswire medicinova to present at the piper jaffray healthcare conference in new york nov   at  am et on globenewswire medicinova announces european medicines agency recommends orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis nov   at  am et on globenewswire medicinova to attend global mizuho investor conference in new york nov   at  pm et on globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the th international symposium on alsmnd in dublin ireland oct   at  pm et on globenewswire medicinova announces fda granted orphan drug designation to mn ibudilast for amyotrophic lateral sclerosis oct   at  pm et on globenewswire options on medicinova common stock listed on cboe sep   at  pm et on globenewswire medicinova receives notice of allowance for new patent covering mn and mn for the treatment of fibrosis jul   at  pm et on globenewswire medicinova inc medicinova inc operates as a biopharmaceutical company with interest in acquiring and developing novel small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the us market the companys development pipeline consists of product development programs which have been in clinical development for the treatment of acute exacerbations of asthma chronic obstructive pulmonary disease exacerbations multiple sclerosis and other neurologic conditions asthma interstitial cystitis solid tumor cancers generalized anxiety disorder preterm labor and two preclinicalstage compounds for the treatment of thrombotic disorders medicinova was founded by yuichi iwaki on september   and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings competitors name chg  market cap biodelivery sciences international inc  m novartis ag adr  b eli lilly  co  b sanofi adr  b alkermes plc  b competitor data provided by partner content trending tickers powered by cri  cb  reml  gpn  txrh  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  mnov stock price  medicinova inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers ctas  cof  etfc  syf  hp  isrg  hban  chk  latest newsall times eastern p updated you can date someone who looks just like donald trump with this new online service p updated want to buy happiness splurge on these  things p this is what people really buy when they emotionally overspend hint it’s not designer clothes p updated john mccain is a war hero — but think twice before saying he’s ‘battling’ cancer p updated the dark side of cruises p updated i want to buy my brothers out of our family home — but they want me to pay future sales fees p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated not even free money can make some people go to the gym p updated how realestate tv shows determine what buyers look for in a house p updated what eleanor roosevelt and helen gurley brown ate — and what we can learn from it to be replaced home investing quotes stocks united states mnov overview compare quotes stock screener earnings calendar sectors nasdaq mnov us nasdaq join td ameritrade find a broker medicinova inc watchlist createmnovalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee na pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones thursday’s top gaining and declining stocks may   at  pm et by marketwatch medicinova dives on asthma study results may   at  pm et by val brickates kennedy hp climbs netapp tumbles in afterhours trade may   at  pm et by carla mozee medicinova study doesnt yield significant results may   at  pm et drug stocks move higher in late trading mar   at  pm et by val brickates kennedy fridays biggest gaining and declining stocks aug   at  pm et by marketwatch the gap jm smucker ann taylor in view aug   at  am et by marketwatch medicinova to acquire avigen for  a share aug   at  am et by william l watts medicinova to buy avigen for share aug   at  am et by steve goldstein avigen holders would get net cash value plus m jun   at  am et by simon kennedy medicinova avigen agree terms of proposed deal jun   at  am et by simon kennedy medicinova reaches tentative deal to buy avigen jun   at  am et by steve goldstein medicinova proposes to acquire avigen dec   at  am et by aude lagorce medicinova makes offer for avigen dec   at  am et by aude lagorce medicinova reports progress in asthmadrug phase ii trial sep   at  am et by robert daniel nedicinova reports positive preliminary phase ii results sep   at  am et by simon kennedy medicinova withdraws plan for secondary stock offering nov   at  am et by mike maynard medicinova pulls public offering of m shares nov   at  am et by aude lagorce medicinova to focus on  drugs to stop asthma drug trial jun   at  am et by sarah turner medicinova to focus on mn mn jun   at  am et by steve goldstein stocks to watch radioshack assisted living concepts caesars entertainment feb   at  am et on the wall street journal signet jewelers medicinova biggest price decliners sig mnov may   at  pm et on the wall street journal stocks to watch hewlettpackard pandora tiffany may   at  am et on the wall street journal bitauto holdings medicinova biggest price gainers bita mnov jun   at  pm et on the wall street journal usana health sciences medicinova biggest price gainers usna mnov jun   at  pm et on the wall street journal railamerica medicinova biggest price decliners ra mnov mar   at  pm et on the wall street journal pzena investment management medicinova biggest price gainers pzn mnov apr   at  pm et on the wall street journal recent news other news press releases blankinship  foster llc buys ishares russell  wisdomtree dividend exfinancials  blankinship  foster llc buys ishares russell  wisdomtree dividend exfinancials fund spdr dow jones industrial average sells ishares msci all country asia ex japan index fund ishares russell  value ishares msci eafe jun   at  pm et on gurufocuscom q medicinova inc q medicinova inc apr   at  pm et on edgar online  edg  q k medicinovas ibudilast shows treatment effect in als patients shares ahead  premarket medicinovas ibudilast shows treatment effect in als patients shares ahead  premarket apr   at  am et on seeking alpha medicinovas mn good trial but what about generic riluzole mar   at  am et on seeking alpha change in leadership for nash coming mar   at  pm et on seeking alpha address to congress quick picks mar   at  am et on seeking alpha k medicinova inc feb   at  pm et on edgar online  edg  q k biggest movers in manufacturing stocks now – akba abio glmd kmph dec   at  am et on investorplacecom medicinovas midstage study of mn in progressive ms to continue as planned dec   at  am et on seeking alpha adds and drops from the nasdaq biotech index dec   at  pm et on seeking alpha outcomes data showed als patients who discontinued treatment with medicinovas ibudilast showed declines in muscle strength dec   at  am et on seeking alpha q medicinova inc oct   at  pm et on edgar online  edg  q k nash event today to inform investors oct   at  am et on seeking alpha  biotechnology stocks to buy now sep   at  am et on investorplacecom allergan examining the premiums paid sep   at  am et on seeking alpha allergans tobira takeover stokes nash stocks sep   at  am et on seeking alpha hottest manufacturing stocks now – tatt tnxp nk aldr aug   at  pm et on investorplacecom  biotechnology stocks to buy now aug   at  am et on investorplacecom  biotechnology stocks to buy now aug   at  am et on investorplacecom some potential nash plays jul   at  pm et on seeking alpha medicinova announces positive results from a glioblastoma animal model study presented at the  american society of clinical oncology annual meeting in chicago illinois medicinova announces positive results from a glioblastoma animal model study presented at the  american society of clinical oncology annual meeting in chicago illinois jun   at  pm et on globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the american academy of neurology aan th annual meeting in boston medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the american academy of neurology aan th annual meeting in boston apr   at  pm et on globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the  american society of clinical oncology annual meeting in chicago illinois apr   at  pm et on globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the th quadrennial meeting of the world federation of neurooncology societies in zurich switzerland feb   at  pm et on globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the american academy of neurology aan th annual meeting in boston feb   at  pm et on globenewswire medicinova announces positive findings from completed trial of mn ibudilast in methamphetamine dependence presented at the th winter conference on brain research feb   at  pm et on globenewswire medicinova to attend mizuho healthcare conference in new york feb   at  pm et on globenewswire medicinova announces publication of positive findings on mn ibudilast in alcohol dependence jan   at  pm et on globenewswire medicinova announces european commission grants orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis dec   at  pm et on globenewswire medicinova announces phase b trial of mn ibudilast in progressive ms will continue as planned following dsmb review of interim efficacy analysis dec   at  am et on globenewswire medicinova added to nasdaq biotechnology index dec   at  am et on globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the th international symposium on alsmnd in dublin ireland dec   at  am et on globenewswire medicinova to present at the piper jaffray healthcare conference in new york nov   at  am et on globenewswire medicinova announces european medicines agency recommends orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis nov   at  am et on globenewswire medicinova to attend global mizuho investor conference in new york nov   at  pm et on globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the th international symposium on alsmnd in dublin ireland oct   at  pm et on globenewswire medicinova announces fda granted orphan drug designation to mn ibudilast for amyotrophic lateral sclerosis oct   at  pm et on globenewswire options on medicinova common stock listed on cboe sep   at  pm et on globenewswire medicinova receives notice of allowance for new patent covering mn and mn for the treatment of fibrosis jul   at  pm et on globenewswire medicinova inc medicinova inc operates as a biopharmaceutical company with interest in acquiring and developing novel small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the us market the companys development pipeline consists of product development programs which have been in clinical development for the treatment of acute exacerbations of asthma chronic obstructive pulmonary disease exacerbations multiple sclerosis and other neurologic conditions asthma interstitial cystitis solid tumor cancers generalized anxiety disorder preterm labor and two preclinicalstage compounds for the treatment of thrombotic disorders medicinova was founded by yuichi iwaki on september   and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings competitors name chg  market cap biodelivery sciences international inc  m novartis ag adr  b eli lilly  co  b sanofi adr  b alkermes plc  b competitor data provided by partner content trending tickers powered by cri  cb  reml  gpn  txrh  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience medicinova inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports medicinova inc  product pipeline review   medicinova inc  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports medicinova inc  product pipeline review  summaryglobal markets direct’s ‘medicinova inc  product pipeline review  ’ provides an overview of the medicinova inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of medicinova inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of medicinova inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of medicinova inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the medicinova inc’s pipeline productsreasons to buy evaluate medicinova inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of medicinova inc in its therapy areas of focus identify new drug targets and therapeutic classes in the medicinova inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of medicinova inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of medicinova inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of medicinova inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures medicinova inc snapshot medicinova inc overview key information key facts medicinova inc  research and development overview key therapeutic areas medicinova inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities medicinova inc  pipeline products glance medicinova inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities medicinova inc  early stage pipeline products preclinical productscombination treatment modalities medicinova inc  drug profiles bedoradrine sulfate product description mechanism of action rd progress ibudilast product description mechanism of action rd progress denibulin hydrochloride product description mechanism of action rd progress tipelukast product description mechanism of action rd progress mn product description mechanism of action rd progress mn product description mechanism of action rd progress medicinova inc  pipeline analysis medicinova inc  pipeline products by target medicinova inc  pipeline products by route of administration medicinova inc  pipeline products by molecule type medicinova inc  pipeline products by mechanism of action medicinova inc  recent pipeline updates medicinova inc  dormant projects medicinova inc  discontinued pipeline products discontinued pipeline product profiles av coagulinb medicinova inc  company statement medicinova inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmedicinova inc key information medicinova inc key facts medicinova inc  pipeline by indication  medicinova inc  pipeline by stage of development  medicinova inc  monotherapy products in pipeline  medicinova inc  partnered products in pipeline  medicinova inc  partnered products combination treatment modalities  medicinova inc  outlicensed products in pipeline  medicinova inc  outlicensed products combination treatment modalities  medicinova inc  phase ii  medicinova inc  phase i  medicinova inc  preclinical  medicinova inc  pipeline by target  medicinova inc  pipeline by route of administration  medicinova inc  pipeline by molecule type  medicinova inc  pipeline products by mechanism of action  medicinova inc  recent pipeline updates  medicinova inc  dormant developmental projects medicinova inc  discontinued pipeline products  medicinova inc subsidiaries list of figuresmedicinova inc  pipeline by top  indication  medicinova inc  pipeline by stage of development  medicinova inc  monotherapy products in pipeline  medicinova inc  partnered products in pipeline  medicinova inc  pipeline by top  target  medicinova inc  pipeline by top  route of administration  medicinova inc  pipeline by top  molecule type  medicinova inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send medicinova inc nasdaqmnov medicinova inc mnov product news news  stocknewscom     follow us stocktwits twitter medicinova inc mnov product news news mnov – announces presentation of ‘positive’ results from an animal model study that examined the potential clinical efficacy of mn ibudilast for the treatment of glioblastoma at  asco jun    pm  by stocknewscom staff product news key facts surrounding this news item mnov had a powr rating of c neutral coming into today mnov was  above its day moving average coming into today mnov was  above its day moving average coming into today mnov was  above its day moving average coming into today mnov was  above its day moving average coming into today mnov was  below its day moving average coming into today mnov had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about medicinova inc mnov medicinova inc a biopharmaceutical company focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs for the united states market the company was founded in  and is based in la jolla california view our full mnov ticker page with ratings news and more mnov at a glance mnov current powr rating™ overall powr rating™ mnov current price   more mnov ratings data and news mnov price reaction the day of this event jun  mnov closing price mnov volume from avgleading up to this eventmnov mo returnafter this eventmnov day returnmnov day returnmnov day return mnov price chart more medicinova inc mnov news view all eventdate symbol news detail start price end price change powr rating loading please wait view all mnov news page generated in  seconds medicinova inc  product pipeline review    reportsnreports market research report welcome guest    registerlogin   contact us   about us      advanced search home ›  pharmaceuticals ›  report detail medicinova inc  product pipeline review   published may  no of pages  price  single user license us   corporate user license us     report description table of contents inquire before buying global markets directs medicinova inc product pipeline review  provides an overview of the medicinova incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of medicinova incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of medicinova inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of medicinova incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the medicinova incs pipeline productsreasons to buyevaluate medicinova incs strategic position with total access to detailed information on its product pipelineassess the growth potential of medicinova inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the medicinova incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of medicinova inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of medicinova incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of medicinova inc and identify potential opportunities in those areasavoid intellectual property rights related issues medicinova inc  product pipeline review   table of contentstable of contents list of tables list of figures medicinova inc snapshot medicinova inc overview key information key facts medicinova inc  research and development overview key therapeutic areas medicinova inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities medicinova inc  pipeline products glance medicinova inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities medicinova inc  early stage pipeline products preclinical productscombination treatment modalities medicinova inc  drug profiles bedoradrine sulfate product description mechanism of action rd progress ibudilast product description mechanism of action rd progress denibulin hydrochloride product description mechanism of action rd progress tipelukast product description mechanism of action rd progress mn product description mechanism of action rd progress mn product description mechanism of action rd progress medicinova inc  pipeline analysis medicinova inc  pipeline products by target medicinova inc  pipeline products by route of administration medicinova inc  pipeline products by molecule type medicinova inc  pipeline products by mechanism of action medicinova inc  recent pipeline updates medicinova inc  dormant projects medicinova inc  discontinued pipeline products discontinued pipeline product profiles av coagulinb medicinova inc  company statement medicinova inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmedicinova inc key information medicinova inc key facts medicinova inc  pipeline by indication  medicinova inc  pipeline by stage of development  medicinova inc  monotherapy products in pipeline  medicinova inc  partnered products in pipeline  medicinova inc  partnered products combination treatment modalities  medicinova inc  outlicensed products in pipeline  medicinova inc  outlicensed products combination treatment modalities  medicinova inc  phase ii  medicinova inc  phase i  medicinova inc  preclinical  medicinova inc  pipeline by target  medicinova inc  pipeline by route of administration  medicinova inc  pipeline by molecule type  medicinova inc  pipeline products by mechanism of action  medicinova inc  recent pipeline updates  medicinova inc  dormant developmental projects medicinova inc  discontinued pipeline products  medicinova inc subsidiaries list of figuresmedicinova inc  pipeline by top  indication  medicinova inc  pipeline by stage of development  medicinova inc  monotherapy products in pipeline  medicinova inc  partnered products in pipeline  medicinova inc  pipeline by top  target  medicinova inc  pipeline by top  route of administration  medicinova inc  pipeline by top  molecule type  medicinova inc  pipeline products by top  mechanism of action   published by global markets direct product code global markets direct did you find what you arewere looking for  if not read below and browse through other relevant pages for similar market research reports or get in touch with us through the formcontact info in your right navigation panel and well share relevant market report titles for you to explore related reports global onychomycosis tinea unguium drug detailed analysis report  this report splits onychomycosis tinea unguium drug by product drug form by product usage type this shares the history data information from  to  and forecast from  to  and this report mainly introduces volume and value marke  united states vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx fro  united states tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in united states from the xx million usd in  with a cagr compound annual growth rate xx from   philippines vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from   philippines tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in philippines from the xx million usd in  with a cagr compound annual growth rate xx from    malaysia vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from   malaysia tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in malaysia from the xx million usd in  with a cagr compound annual growth rate xx from  to   japan vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  t  japan tuberculin market report status and outlook this report will be delivered in  business days after the order is placed the tuberculin market size will be xx million usd in  in japan from the xx million usd in  with a cagr compound annual growth rate xx from  to   india vaginal pessary market report status and outlook this report will be delivered in  business days after the order is placed the vaginal pessary market size will be xx million usd in  in india from the xx million usd in  with a cagr compound annual growth rate xx from  t why reportsnreportscom  market research reports and growing top fortune  organizations trust us for research data  support on call as well as emails your details are safe with us free support for your research requirements report delivery email delivery time upto  hrs  working days upto  hrs max  weekends and public holidays research support  custom research if this business study does not have the data and information analysis you need contact us with your research requirements we explore available market research reports to map your needs and share report titles with you alternatively we can also offer custom research that suits your budget and timelines share your information requirements here connect with us email salesreportsandreportscom call       home category publisher country latest reports markets discounted reports upcoming reports contact us subscription option using our subscription option you get access to market research reports and industry data of consumer goods market as per your needs get the best of consumer goods research reports by utilizing your research budgets in an optimum way more about our subscription option report alerts get email alerts about market research reports from industries and publishers of your interest please enter a valid email id thank you you have successfully subscribed to our report alerts avail upto  discount on below publisher reports technavio azoth analytics   reportsnreports all rights reserved disclamer privacy policy  terms and conditions  our market research blog  sitemap feeds rss  latest reports mnov key statistics  medicinova inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close medicinova inc nasdaq mnov go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus medicinova inc after hours  quotes are delayed by  min jul    pm mnov quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description medicinova inc operates as a biopharmaceutical company with interest in acquiring and developing novel small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the us market the companys development pipeli medicinova inc operates as a biopharmaceutical company with interest in acquiring and developing novel small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the us market the companys development pipeline consists of product development programs which have been in clinical development for the treatment of acute exacerbations of asthma chronic obstructive pulmonary disease exacerbations multiple sclerosis and other neurologic conditions asthma interstitial cystitis solid tumor cancers generalized anxiety disorder preterm labor and two preclinicalstage compounds for the treatment of thrombotic disorders medicinova was founded by yuichi iwaki on september   and is headquartered in san diego ca valuation pe current  pe ratio with extraordinary items  price to book ratio  enterprise value to ebitda  efficiency income per employee  liquidity current ratio  quick ratio  cash ratio  profitability return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title dr yuichi iwaki   president chief executive officer  director mr ryan j selhorn   chief financial officer dr kazuko matsuda   chief medical officer mr masatsune okajima   vice president  headjapanese office mr geoffrey g obrien   vice president  headinvestor relations insider actions – purchase – sale  – number of transactions  date name shares transaction value  yutaka kobayashi director    acquisition at  per share   yutaka kobayashi director    acquisition at  per share   yutaka kobayashi director    acquisition at  per share   yutaka kobayashi director    acquisition at  per share   geoffrey g obrien vice president    disposition at  per share   geoffrey g obrien vice president    derivativenonderivative trans at  per share   kazuko matsuda chief medical officer      masatsune okajima vp and head of japanese office      yutaka kobayashi director    acquisition at  per share   yutaka kobayashi director    acquisition at  per share   yutaka kobayashi director    acquisition at  per share   yoshio ishizaka director    acquisition at  per share  newslatestcompanyusmnov marketwatch news on mnov thursday’s top gaining and declining stocks  pm may    marketwatch medicinova dives on asthma study results  pm may    val brickates kennedy hp climbs netapp tumbles in afterhours trade  pm may    carla mozee medicinova study doesnt yield significant results  pm may    marketwatchcom drug stocks move higher in late trading  pm march    val brickates kennedy fridays biggest gaining and declining stocks  pm aug    marketwatch the gap jm smucker ann taylor in view  am aug    marketwatch medicinova to acquire avigen for  a share  am aug    william l watts medicinova to buy avigen for share  am aug    steve goldstein avigen holders would get net cash value plus m  am june    simon kennedy medicinova avigen agree terms of proposed deal  am june    simon kennedy medicinova reaches tentative deal to buy avigen  am june    steve goldstein medicinova proposes to acquire avigen  am dec    aude lagorce medicinova makes offer for avigen  am dec    aude lagorce medicinova reports progress in asthmadrug phase ii trial  am sept    robert daniel nedicinova reports positive preliminary phase ii results  am sept    simon kennedy medicinova withdraws plan for secondary stock offering  am nov    mike maynard medicinova pulls public offering of m shares  am nov    aude lagorce medicinova to focus on  drugs to stop asthma drug trial  am june    sarah turner medicinova to focus on mn mn  am june    steve goldstein loading more headlines newsnonmarketwatchcompanyusmnov other news on mnov blankinship  foster llc buys ishares russell  wisdomtree dividend exfinancials   pm june    gurufocuscom q medicinova inc  pm april    edgar online  edg  q k medicinovas ibudilast shows treatment effect in als patients shares ahead  premarket  am april    seeking alpha medicinovas mn good trial but what about generic riluzole  am march    seeking alpha change in leadership for nash coming  pm march    seeking alpha address to congress quick picks  am march    seeking alpha k medicinova inc  pm feb    edgar online  edg  q k biggest movers in manufacturing stocks now – akba abio glmd kmph  am dec    investorplacecom medicinovas midstage study of mn in progressive ms to continue as planned  pm dec    seeking alpha adds and drops from the nasdaq biotech index  pm dec    seeking alpha outcomes data showed als patients who discontinued treatment with medicinovas ibudilast showed declines in muscle strength  am dec    seeking alpha q medicinova inc  pm oct    edgar online  edg  q k nash event today to inform investors  am oct    seeking alpha  biotechnology stocks to buy now  am sept    investorplacecom allergan examining the premiums paid  am sept    seeking alpha allergans tobira takeover stokes nash stocks  am sept    seeking alpha hottest manufacturing stocks now – tatt tnxp nk aldr  pm aug    investorplacecom  biotechnology stocks to buy now  am aug    investorplacecom  biotechnology stocks to buy now  am aug    investorplacecom some potential nash plays  pm july    seeking alpha loading more headlines at a glance medicinova inc  executive square suite  la jolla california  phone   industry pharmaceuticals sector health carelife sciences fiscal yearend  view sec filings revenue na net income m employees  annual report for mnov newspressreleasecompanyusmnov press releases on mnov medicinova announces positive results from a glioblastoma animal model study presented at the  american society of clinical oncology annual meeting in chicago illinois  pm june    globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the american academy of neurology aan th annual meeting in boston  pm april    globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the  american society of clinical oncology annual meeting in chicago illinois  pm april    globenewswire medicinova announces mn ibudilast glioblastoma abstract selected for presentation at the th quadrennial meeting of the world federation of neurooncology societies in zurich switzerland  pm feb    globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the american academy of neurology aan th annual meeting in boston  pm feb    globenewswire medicinova announces positive findings from completed trial of mn ibudilast in methamphetamine dependence presented at the th winter conference on brain research  pm feb    globenewswire medicinova to attend mizuho healthcare conference in new york  pm feb    globenewswire medicinova announces publication of positive findings on mn ibudilast in alcohol dependence  pm jan    globenewswire medicinova announces european commission grants orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis  pm dec    globenewswire medicinova announces phase b trial of mn ibudilast in progressive ms will continue as planned following dsmb review of interim efficacy analysis  am dec    globenewswire medicinova added to nasdaq biotechnology index  am dec    globenewswire medicinova announces exploratory interim clinical outcomes data from clinical trial of mn ibudilast in als presented at the th international symposium on alsmnd in dublin ireland  am dec    globenewswire medicinova to present at the piper jaffray healthcare conference in new york  am nov    globenewswire medicinova announces european medicines agency recommends orphan medicinal product designation for mn ibudilast for amyotrophic lateral sclerosis  am nov    globenewswire medicinova to attend global mizuho investor conference in new york  pm nov    globenewswire medicinova announces mn ibudilast als abstract accepted for presentation at the th international symposium on alsmnd in dublin ireland  pm oct    globenewswire medicinova announces fda granted orphan drug designation to mn ibudilast for amyotrophic lateral sclerosis  pm oct    globenewswire options on medicinova common stock listed on cboe  pm sept    globenewswire medicinova receives notice of allowance for new patent covering mn and mn for the treatment of fibrosis  pm july    globenewswire trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  page not found  medgadget  not found apologies but the page you requested could not be found perhaps searching will help at medgadget we report on the latest medical technology news interview leaders in the field and file dispatches from medical events from around the world about contact terms of service privacy submit press release advertise  medgadget llc  all rights reserved  the medical revolution will be blogged mnov profile  medicinova inc stock  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets closedsp  dow  listenaetnas ceo mark bertolini on the future of the health care systembertolini shares how a lifethreatening injury shaped his views on health caremedicinova inc mnovnasdaqgm  nasdaqgm delayed price currency in usdadd to watchlist at close pm edtpeople also watchcytkopxatthilxrxgtxisummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsmedicinova inc executive squaresuite la jolla ca united stateshttpmedicinovacomsector healthcareindustry biotechnologyfull time employees key executivesnametitlepayexercisedagedr yuichi iwaki md phdcofounder chief exec officer pres and exec directorknamr ryan j selhornchief financial officer and principal accounting officerknamr masatsune okajimahead of japanese office and vpknadr kazuko matsuda md phd mphchief medical officerknamr geoffrey g obrien jd mbavpkkamounts are as of december   and compensation values are for the last fiscal year ending on that date pay is salary bonuses etc exercised is the value of options exercised during the fiscal year currency in usddescriptionmedicinova inc a biopharmaceutical company focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the united states the companys product candidate includes mn ibudilast an oral antiinflammatory and neuroprotective agent for the treatment of neurological disorders including primary and secondary progressive multiple sclerosis amyotrophic lateral sclerosis and substance dependence and addiction including methamphetamine opioid and alcohol dependence its product pipeline also comprises mn tipelukast an orally bioavailable small molecule compound to treat fibrotic diseases such as nonalcoholic steatohepatitis idiopathic pulmonary fibrosis and other fibrotic diseases mn bedoradrine a ßadrenergic receptor agonist for the treatment of acute exacerbation of asthma and mn denibulin a tubulin binding agent to treat solid tumor cancers the company was founded in  and is headquartered in la jolla californiacorporate governancemedicinova inc’s iss governance qualityscore as of july   is  the pillar scores are audit  board  shareholder rights  compensation corporate governance scores courtesy of institutional shareholder services iss scores indicate decile rank relative to index or region a decile score of  indicates lower governance risk while a  indicates higher governance riskyahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated home  medicinova inc japanese site 語 search the site medicinova is a biopharmaceutical company that is developingnovel therapeutics with a primary focus on neurology respiratoryand liver diseases with unmet medical needs mn for neurology diseases progressive multiple sclerosis amyotrophic lateral sclerosis als drug dependence learn more mn for respiratory diseases acute exacerbations of asthma copd exacerbations learn more mn for fibrotic diseases liver fibrosis nash or others pulmonary fibrosis ipf learn more bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one